Cargando…

Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study

BACKGROUND: Statistical methods for modeling longitudinal and time-to-event data has received much attention in medical research and is becoming increasingly useful. In clinical studies, such as cancer and AIDS, longitudinal biomarkers are used to monitor disease progression and to predict survival....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngwa, Julius S., Cabral, Howard J., Cheng, Debbie M., Gagnon, David R., LaValley, Michael P., Cupples, L. Adrienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876802/ https://www.ncbi.nlm.nih.gov/pubmed/33568059 http://dx.doi.org/10.1186/s12874-021-01207-y

Ejemplares similares

A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study
por: Ngwa, Julius S., et al.
Publicado: (2016)

Description of the Framingham Heart Study data for Genetic Analysis Workshop 13
por: Cupples, L Adrienne, et al.
Publicado: (2003)

Consistency of linkage results across exams and methods in the Framingham Heart Study
por: Atwood, Larry D, et al.
Publicado: (2003)

Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data
por: Cupples, L Adrienne, et al.
Publicado: (2009)

Genome-wide association with diabetes-related traits in the Framingham Heart Study
por: Meigs, James B, et al.
Publicado: (2007)

Association of Obesity With Mortality Over 24 Years of Weight History: Findings From the Framingham Heart Study
por: Xu, Hanfei, et al.
Publicado: (2018)

Longitudinal variance-components analysis of the Framingham Heart Study data
por: Macgregor, Stuart, et al.
Publicado: (2003)

Genome-Wide Linkage and Association Scans for Quantitative Trait Loci of Serum Lactate Dehydrogenase—The Framingham Heart Study
por: Lin, Jing-Ping, et al.
Publicado: (2010)

Comparing baseline and longitudinal measures in association studies
por: Wang, Shuai, et al.
Publicado: (2014)

Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project
por: Fox, Caroline S, et al.
Publicado: (2007)

Comparison of two methods for analysis of gene–environment interactions in longitudinal family data: the Framingham heart study
por: Sung, Yun Ju, et al.
Publicado: (2014)

Genome-Wide Pleiotropy of Osteoporosis-Related Phenotypes: The Framingham Study
por: Karasik, David, et al.
Publicado: (2010)

Multiple imputation methods for longitudinal blood pressure measurements from the Framingham Heart Study
por: Kang, Terri, et al.
Publicado: (2003)

Multilevel modeling for the analysis of longitudinal blood pressure data in the Framingham Heart Study pedigrees
por: Briollais, Laurent, et al.
Publicado: (2003)

A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study
por: Kathiresan, Sekar, et al.
Publicado: (2007)

Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trials
por: Reichmann, William M, et al.
Publicado: (2013)

Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study
por: Aparicio, Hugo J., et al.
Publicado: (2017)

The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
por: Felson, David T, et al.
Publicado: (2014)

Comparison of year-of-exam- and age-matched estimates of heritability in the Framingham Heart Study data
por: Mathias, Rasika A, et al.
Publicado: (2003)

Sex and age specific effects of chromosomal regions linked to body mass index in the Framingham Study
por: Atwood, Larry D, et al.
Publicado: (2006)

Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study
por: O'Donnell, Christopher J, et al.
Publicado: (2007)

Power of linkage analysis using traits generated from simulated longitudinal data of the Framingham Heart Study
por: Wang, Dai, et al.
Publicado: (2003)

Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
por: Corlin, Laura, et al.
Publicado: (2020)

Prognostic Outcomes of Tall Cell Variant Papillary Thyroid Cancer: A Meta-Analysis
por: Jalisi, Scharukh, et al.
Publicado: (2010)

Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder
por: Hausman-Cohen, Sharon, et al.
Publicado: (2022)

A genome-wide association analysis of Framingham Heart Study longitudinal data using multivariate adaptive splines
por: Zhu, Wensheng, et al.
Publicado: (2009)

Associating multiple longitudinal traits with high-dimensional single-nucleotide polymorphism data: application to the Framingham Heart Study
por: Waaijenborg, Sandra, et al.
Publicado: (2009)

Protective Effect of High Protein and Calcium Intake on the Risk of Hip Fracture in the Framingham Offspring Cohort
por: Sahni, Shivani, et al.
Publicado: (2010)

Haplotype Structure of the ENPP1 Gene and Nominal Association of the K121Q Missense Single Nucleotide Polymorphism With Glycemic Traits in the Framingham Heart Study
por: Stolerman, Elliot S., et al.
Publicado: (2008)

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study
por: Goode, Ellen L, et al.
Publicado: (2003)

Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes
por: Larson, Martin G, et al.
Publicado: (2007)

Digital Connectedness in the Framingham Heart Study
por: Fox, Caroline S., et al.
Publicado: (2016)

Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study
por: Hivert, Marie-France, et al.
Publicado: (2009)

Whole genome sequence analyses of brain imaging measures in the Framingham Study
por: Sarnowski, Chloé, et al.
Publicado: (2018)

Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2018)

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
por: Ananthakrishnan, Revathi, et al.
Publicado: (2019)

Reply
por: Felson, David, et al.
Publicado: (2022)

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
por: Lowe, Leroy, et al.
Publicado: (2022)

Multivariate variance-components analysis of longitudinal blood pressure measurements from the Framingham Heart Study
por: Kraft, Peter, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_on42skbl19oq6681i7qp15qgl1